These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24949551)

  • 1. Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides.
    Hegemann JD; De Simone M; Zimmermann M; Knappe TA; Xie X; Di Leva FS; Marinelli L; Novellino E; Zahler S; Kessler H; Marahiel MA
    J Med Chem; 2014 Jul; 57(13):5829-34. PubMed ID: 24949551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation.
    Mas-Moruno C; Beck JG; Doedens L; Frank AO; Marinelli L; Cosconati S; Novellino E; Kessler H
    Angew Chem Int Ed Engl; 2011 Sep; 50(40):9496-500. PubMed ID: 21948451
    [No Abstract]   [Full Text] [Related]  

  • 3. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
    Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
    Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
    Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
    J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structure.
    Marelli UK; Frank AO; Wahl B; La Pietra V; Novellino E; Marinelli L; Herdtweck E; Groll M; Kessler H
    Chemistry; 2014 Oct; 20(44):14201-6. PubMed ID: 25251673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics and functional differences between dendroaspin and rhodostomin: insights into protein scaffolds in integrin recognition.
    Cheng CH; Chen YC; Shiu JH; Chang YT; Chang YS; Huang CH; Chen CY; Chuang WJ
    Protein Sci; 2012 Dec; 21(12):1872-84. PubMed ID: 23033223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design and activity determination of small molecular inhibitors of integrin alphavbeta3].
    Ji Q; Zhou Y; Peng H; Huang N; Qi J; Xiong DS; Gao YD; Yang M; Yang CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):347-52. PubMed ID: 17633460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptor.
    Heckmann D; Meyer A; Marinelli L; Zahn G; Stragies R; Kessler H
    Angew Chem Int Ed Engl; 2007; 46(19):3571-4. PubMed ID: 17394271
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic peptides derived from the sequence of a lasso peptide microcin J25 show antibacterial activity.
    Soudy R; Wang L; Kaur K
    Bioorg Med Chem; 2012 Mar; 20(5):1794-800. PubMed ID: 22304849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to α
    Nardelli F; Paissoni C; Quilici G; Gori A; Traversari C; Valentinis B; Sacchi A; Corti A; Curnis F; Ghitti M; Musco G
    J Med Chem; 2018 Sep; 61(17):7474-7485. PubMed ID: 29883545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human integrin alphavbeta5: homology modeling and ligand binding.
    Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
    J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis.
    Trikha M; De Clerck YA; Markland FS
    Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-emptive and therapeutic value of blocking bacterial attachment to the endothelial alphaVbeta3 integrin with cilengitide in sepsis.
    Garciarena CD; McHale TM; Martin-Loeches I; Kerrigan SW
    Crit Care; 2017 Sep; 21(1):246. PubMed ID: 28946901
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1.
    Van Agthoven JF; Shams H; Cochran FV; Alonso JL; Kintzing JR; Garakani K; Adair BD; Xiong JP; Mofrad MRK; Cochran JR; Arnaout MA
    Structure; 2019 Sep; 27(9):1443-1451.e6. PubMed ID: 31353240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule integrin antagonists in cancer therapy.
    Paolillo M; Russo MA; Serra M; Colombo L; Schinelli S
    Mini Rev Med Chem; 2009 Oct; 9(12):1439-46. PubMed ID: 19929817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear and Cyclic Depsipeptidomimetics with β-Lactam Cores: A Class of New α
    Zabala-Uncilla N; Miranda JI; Laso A; Fernández X; Ganboa JI; Palomo C
    Chembiochem; 2017 Apr; 18(7):654-665. PubMed ID: 28140512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
    Haas TA
    Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
    Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
    Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
    Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
    Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells.
    Morjen M; Kallech-Ziri O; Bazaa A; Othman H; Mabrouk K; Zouari-Kessentini R; Sanz L; Calvete JJ; Srairi-Abid N; El Ayeb M; Luis J; Marrakchi N
    Matrix Biol; 2013 Jan; 32(1):52-62. PubMed ID: 23262217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.